ESC Professional Premium Access

Risk factors and clinical effects of late leaflet thrombosis after transcatheter aortic valve replacement

Congress Presentation

About the speaker

Doctor Minjung Bak

Samsung Medical Center, Seoul (Korea (Republic of))
0 follower

4 more presentations in this session

To compare efficacy and safety of direct oral anticoagulants in patients with concurrent atrial fibrillation and bioprosthetic heart valve repair or replacement: a systematic review and meta-analysis

Speaker: Doctor A. Kaur (New York City, US)


Oral anticoagulant treatment in patients with atrial fibrillation early after valvular intervention: a nationwide cohort study

Speaker: Associate Professor C. Christersson (Uppsala, SE)


Comparing direct oral anticoagulants versus vitamin k antagonist in patients with atrial fibrillation after transcatheter aortic valve replacement: an updated meta-analysis

Speaker: Doctor A. Kaur (New York City, US)


Hypoattenuated leaflet thickening is associated with silent brain injury

Speaker: Doctor A. Nagy (Budapest, HU)


Access the full session

Thrombosis and anticoagulation in valvular heart disease

Speakers: Doctor M. Bak, Doctor A. Kaur, Associate Professor C. Christersson, Doctor A. Kaur, Doctor A. Nagy

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb